Ingredients in every tablet
Each package contains
|ATC Level 1||R - Respiratory system|
|ATC Level 2||R03 - Drugs for Obstructive Airway Diseases|
|ATC Level 3||R03D - Other Systemic Drugs for Obstructive Airway Diseases in ATC|
0 TO 15 YEARS OLD
Montelukast 10 mg tablets should not be prescribed.
15 YEARS OLD AND ABOVE
Monarin should be taken once daily in the evening (one-10 mg tablet)
— Exercise-Induced Bronchoconstriction (EIB)
For prevention of EIB, a single dose (one-10 mg tablet) of Monarin should be taken at least 2 hours before exercise.
An additional dose of Monarin should not be taken within 24 hours of a previous dose. Patients already taking Monarin daily for another indication (including chronic asthma) should not take an additional dose to prevent EIB. All patients should have available for rescue a short-acting β-agonist. Daily administration of Monarin for the chronic treatment of asthma has not been established to prevent acute episodes of EIB.
The therapeutic effect of montelukast on parameters of asthma control occurs within one day. Montelukast may be taken with or without food. Patients should be advised to continue taking montelukast even if their asthma is under control, as well as during periods of worsening asthma.
PATIENTS WITH RENAL IMPAIRMENT
No dosage adjustment is necessary for patients with renal insufficiency.
PATIENTS WITH MILD TO MODERATE HEPATIC IMPAIRMENT
No dosage adjustment is necessary for patients with mild to moderate hepatic impairment.
Monarin is indicated in Adults for the prophylaxis and chronic treatment of asthma, including the prevention of exercise-induced bronchoconstriction.